COMMON STOCK PURCHASE WARRANT MAIA BIOTECHNOLOGY, INC.MAIA Biotechnology, Inc. • November 16th, 2023 • Pharmaceutical preparations • New York
Company FiledNovember 16th, 2023 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alumni Capital LP or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 10, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 10, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from MAIA BIOTECHNOLOGY, INC., a Delaware corporation (the “Company”), up to 250,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).